SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0000950170-23-067157
Filing Date
2023-12-01
Accepted
2023-12-01 08:56:00
Documents
76
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 6-K frln-20230930.htm   iXBRL 6-K 1425732
2 EX-99.1 frln-ex99_1.htm EX-99.1 161866
3 GRAPHIC img173576535_0.jpg GRAPHIC 11135
  Complete submission text file 0000950170-23-067157.txt   6900185

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT frln-20230930_pre.xml EX-101.PRE 366859
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT frln-20230930_def.xml EX-101.DEF 232290
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT frln-20230930_lab.xml EX-101.LAB 463029
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT frln-20230930_cal.xml EX-101.CAL 58861
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT frln-20230930.xsd EX-101.SCH 62145
70 EXTRACTED XBRL INSTANCE DOCUMENT frln-20230930_htm.xml XML 1017921
Mailing Address SYCAMORE HOUSE GUNNELS WOOD ROAD, STEVENAGE HERTFORDSHIRE X0 SG1 2BP
Business Address SYCAMORE HOUSE GUNNELS WOOD ROAD, STEVENAGE HERTFORDSHIRE X0 SG1 2BP 44 (0)1438 906870
Freeline Therapeutics Holdings plc (Filer) CIK: 0001810031 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39431 | Film No.: 231457662
SIC: 2836 Biological Products, (No Diagnostic Substances)